&w=3840&q=100)
Alembic Pharma dips 3% post Q1 results; MOFSL retains Neutral, here's why
At 1:35 PM, Alembic was trading 1.7 per cent lower at ₹931 on the NSE. In comparison, the NSE Nifty was trading lower by 0.13 per cent at 24,618.45. The stock has crashed around 27 per cent from its 52-week high of ₹1,303.9 touched on October 9, 2024. CATCH STOCK MARKET UPDATES TODAY LIVE In addition, the overall muted sentiment around pharma stocks after US President Donald Trump hinted at as much as a 250 per cent tariff rate in 12 to 18 months also impacted the stock. The Nifty Pharma index fell as much as 1.8 per cent on Wednesday.
Alembic Pharmaceuticals Q1 results
The company reported a 14 per cent increase in consolidated net profit year-on-year (Y-o-Y) to ₹154.33 crore for the Q1FY26 compared to ₹131.21 crore in the year-ago period. Revenue from operations also rose by 10 per cent Y-o-Y to ₹1,710.72 crore against ₹1,561.73 crore in Q1FY25.
Alembic's India branded business witnessed 5 per cent Y-o-Y growth to ₹599 crore in the quarter under review. United States generic revenue also grew 13 per cent to ₹523 crore, on the back of four new launches in the market. The company secured six abbreviated new drug application (ANDA) approvals during the quarter, bringing total approvals to 223. The active pharmaceutical ingredient (API) business grew marginally by 1 per cent, with revenue of ₹261 crore for the quarter.
Alembic Pharma Q1 results analysis - Motilal Oswal Financial Services
According to analysts at MOFSL, Alembic Pharma delivered a largely in-line performance for 1QFY26 as superior execution in the export market led to Y-o-Y growth in revenue/Ebitda/PAT for the quarter. However, this growth was offset, to some
extent, by a muted show in the domestic formulation (DF) and API segments.
Alembic Pharma maintained its growth momentum in the US market on the back of new launches. Notably, upcoming introductions such as g-Entresto have the potential to further strengthen growth in the US generics segment. That said, a broader scope of business would be necessary to enhance capacity utilisation and, in turn, improve the profitability of the US generics segment, MOFSL said in a note.
"After a muted performance in FY25, ALPM is working to improve business prospects across its key markets. Growth in export markets is strengthening on the back of new launches and superior supply chain management. Considering these aspects, we expect a 24 per cent earnings compound annual growth rate (CAGR) over FY25-27. The current valuation largely factors in the earnings upside," the brokerage said.
MOFSL has maintained a 'Neutral' rating on the stock with a target price of ₹990.
About Alembic Pharma
Incorporated in 2010, Alembic Pharmaceuticals is engaged in the business of development, manufacturing, and marketing of pharmaceutical products, including formulations and active pharmaceutical ingredients. Its products can be broadly classified into active pharmaceutical ingredients (APIs), formulations, and international generics. Alembic's customers include pharmaceutical companies for APIs, healthcare facilities and patients for formulations, and healthcare facilities and patients for international generics. It has presence across 33 states and union territories in India and 78 countries globally.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
13 minutes ago
- The Hindu
Andhra Pradesh shrimp farmers seek govt. support amid export tariff woes
In a joint meeting held in Ongole on Tuesday, shrimp farmers' associations from Tirupati, Nellore, Prakasam, Bapatla, Guntur, and Krishna districts urged the Andhra Pradesh government to step in and address pressing challenges facing the aquaculture sector. Prakasam District Shrimp Farmers Association president Duggineni Gopinath highlighted that the sector has been hit hard since former U.S. President Donald Trump increased tariffs on Indian shrimp imports. 'Nearly 40% of our exports go to the U.S., and the increased tariff has severely hurt our earnings,' he said. Gopinath appealed to the State government to provide 50% subsidy on bank loans for setting up mini processing plants. He also suggested including shrimp in the food menus of social welfare hostels and anganwadi centres to boost domestic consumption. The farmer leaders demanded a minimum support price (MSP) of ₹470 per kg for 30-count tiger prawns and ₹400 per kg for 30-count Vannamei shrimp. They also sought uninterrupted power supply at ₹1.50 per unit without additional charges, and urged feed companies to lower prices by at least ₹15 per kg. Resolving to diversify their markets, the farmers said they will focus more on domestic sales and explore exports to South Korea and European countries, rather than depending solely on the U.S. and China.
India.com
13 minutes ago
- India.com
Donald Trump's sanctions working? SBI bans transactions of Nayara Energy with Russian connection due to...
Donald Trump- File image New Delhi: In a significant development amid the US's increasing pressure on India over economic and trade relations with India, the State Bank of India (SBI) has stopped handling Nayara Energy's trade and foreign exchange transactions due to concerns over US and EU sanctions following a recent US tariff hike. Notably, Nayara, formerly Essar Oil, was acquired in 2017 by a Rosneft-led group and operates India's second-largest refinery (20 MTPA) with 8% of national refining capacity and over 6,500 petrol pumps. Why SBI has banned transactions of Nayara Energy? The Russian company Nayara Energy imports crude, refines it into fuels, and sells domestically and overseas. The trade with troubles escalated after the EU's July sanctions package capped Russian crude prices at $47.6 per barrel, making transactions more difficult amid the increasing threats of tariffs from US. Microsoft restores services to Russian oil firm Nayara Energy In another significant update, Tech giant Microsoft informed that services were restored to the Russia-backed oil exploration and marketing company Nayara Energy, two days after Nayara alleged that Microsoft had abruptly cut off access to its data and services. In a statement, the company said it is 'committed to supporting all its customers in India and worldwide and has restored services for Nayara Energy'. 'We are engaged in ongoing discussions with the European Union towards service continuity for the organisation,' said a company. How is Nayara Energy related to Russia? Nayara Energy, which operates fuel retail outlets in India, is primarily owned by Russia's Rosneft, which owns nearly 49 per cent of the company. Trafigura and UCP Investment Group, both foreign companies, jointly own the majority of the remaining stake via an Indian consortium. Earlier this week, Nayara Energy filed a petition in the Delhi High Court, alleging that the US-based technology firm abruptly and unilaterally suspended essential services without notice. (With inputs from agencies)
Economic Times
13 minutes ago
- Economic Times
Hindalco Q1 profit rises 30% as Novelis outlook brightens for H2
The worst is behind for Novelis in several ways, said Satish Pai, managing director of Hindalco Industries. ADVERTISEMENT 'By the second half of this year, you should start to see a very positive turn to Novelis,' he said on Tuesday. Hindalco Industries, which reported its consolidated earnings on Tuesday, saw a 30% jump in its consolidated net profit for the June quarter at Rs 4,004 crore, with consolidated revenue from operations 13% higher at Rs 64,232 crore. Novelis, the wholly-owned US-based subsidiary of the company, reported a 36% fall in its net income for the June quarter at $96 million, while the adjusted EBITDA made on each tonne of aluminium stood at $432, down by 18% on-year. Structurally higher scrap prices negatively impacted performance during the quarter, Novelis said on Monday.'Scrap spreads have started to improve, most particularly in the US. So, we are now hoping, that will get better in the coming quarters,' Pai said on Tuesday. 'The supply of scrap in the US has also gone up, so scrap spreads are no more a headwind, but have started to become a tailwind,' he said on a call after the company's quarterly September and December quarters of the last fiscal were the peak in terms of scrap prices, he said, with prices now turning favourable. ADVERTISEMENT While the June quarter is the 'bottom' in many ways, the September quarter will be similar. 'By Q3, Q4 of this year, you are going to see a much stronger and healthier Novelis,' he said. Earnings in the second half of the year will reflect the impact of mitigation of the spreads, cost reduction programmes and the scrap spreads improving, Pai said. Unlock 500+ Stock Recos on App For its upstream aluminium business in India, Hindalco's earnings before interest, tax, depreciation and amortization (EBITDA) rose 17% on-year to Rs 4,080 crore. The upstream EBITDA per tonne stood at $1,467, up 15% compared to the previous year. In the downstream aluminium business, EBITDA per tonne surged 92% on-year to $264, while EBITDA was at a record high of Rs 229 crore, up 108% on-year. ADVERTISEMENT In the copper business, EBITDA stood at Rs 673 crore, with the sharply declining TC/RCs offset by higher realisation from sulphuric acid, the company said in a statement. At a consolidated level, the company's EBITDA rose 9% on-year to Rs 8,673 reported its earnings during market hours and its shares closed at Rs 666.95 apiece on the BSE, down 0.7% from the previous close. ADVERTISEMENT (You can now subscribe to our ETMarkets WhatsApp channel)
